Literature DB >> 24246601

Cardiogenic shock as the initial presentation of neonatal systemic hypertension.

N Xiao1, A Tandon, S Goldstein, A Lorts.   

Abstract

Neonatal systemic hypertension is an underappreciated etiology of cardiac failure. We present a series of three neonates who presented in cardiogenic shock secondary to severe hypertension, recognized after initial resuscitation efforts. Although the underlying etiology of the hypertension varied, all three patients had improved hemodynamics after their blood pressure was controlled. These cases suggest that neonates presenting in cardiogenic shock with hypertension, and without structural heart disease, may benefit from a thorough renal evaluation and institution of anti-hypertensive therapy.

Entities:  

Keywords:  Infant; cardiogenic shock; hypertension; neonate

Mesh:

Substances:

Year:  2013        PMID: 24246601     DOI: 10.3233/NPM-1370213

Source DB:  PubMed          Journal:  J Neonatal Perinatal Med        ISSN: 1878-4429


  5 in total

Review 1.  Neonatal hypertension: cases, causes, and clinical approach.

Authors:  Michelle C Starr; Joseph T Flynn
Journal:  Pediatr Nephrol       Date:  2018-05-28       Impact factor: 3.714

Review 2.  Systemic Hypertension in Infants with Bronchopulmonary Dysplasia.

Authors:  Michelle C Starr; Amy C Wilson
Journal:  Curr Hypertens Rep       Date:  2022-03-10       Impact factor: 5.369

3.  Hypertensive crisis in children and adolescents.

Authors:  Tomáš Seeman; Gilad Hamdani; Mark Mitsnefes
Journal:  Pediatr Nephrol       Date:  2018-10-01       Impact factor: 3.714

4.  Hypertension secondary to renal hypoplasia presenting as acute heart failure in a newborn.

Authors:  Jena Deitrick; Kayle Stevenson; Daniel Nguyen; William Sessions; Vijay Linga; Tetyana Vasylyeva
Journal:  Clin Hypertens       Date:  2019-05-01

Review 5.  Hypertensive Crisis in Pediatric Patients: An Overview.

Authors:  Rupesh Raina; Zubin Mahajan; Aditya Sharma; Ronith Chakraborty; Sarisha Mahajan; Sidharth K Sethi; Gaurav Kapur; David Kaelber
Journal:  Front Pediatr       Date:  2020-10-20       Impact factor: 3.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.